EcoDrugPlus

Ensembl ID : ENSUAMG00000006551
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSUAMG00000006318
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSUAMG00000016418
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSUAMG00000006633
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSUAMG00000014272
Gene Symbol: -
Cross references: -
120 Possible Orthologues:

Ensembl ID : ENSUAMG00000011932
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSUAMG00000009908
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSUAMG00000011406
Gene Symbol: -
Cross references: -
56 Possible Orthologues:

Ensembl ID : ENSUAMG00000010843
Gene Symbol: -
Cross references: -
263 Possible Orthologues:

Ensembl ID : ENSUAMG00000011757
Gene Symbol: -
Cross references: -
88 Possible Orthologues:

Ensembl ID : ENSUAMG00000010232
Gene Symbol: -
Cross references: -
236 Possible Orthologues:

Ensembl ID : ENSUAMG00000009505
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).